0001493152-22-016972.txt : 20220616 0001493152-22-016972.hdr.sgml : 20220616 20220616161528 ACCESSION NUMBER: 0001493152-22-016972 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20220616 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220616 DATE AS OF CHANGE: 20220616 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rennova Health, Inc. CENTRAL INDEX KEY: 0000931059 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 680370244 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35141 FILM NUMBER: 221020759 BUSINESS ADDRESS: STREET 1: 400 S. AUSTRALIAN AVENUE, SUITE 800 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 BUSINESS PHONE: 561-855-1626 MAIL ADDRESS: STREET 1: 400 S. AUSTRALIAN AVENUE, SUITE 800 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 FORMER COMPANY: FORMER CONFORMED NAME: CollabRx, Inc. DATE OF NAME CHANGE: 20120926 FORMER COMPANY: FORMER CONFORMED NAME: TEGAL CORP /DE/ DATE OF NAME CHANGE: 19950918 8-K 1 form8-k.htm
0000931059 false 0000931059 2022-06-16 2022-06-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT

TO SECTION 13 or 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): June 16, 2022

 

Rennova Health, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

001-35141   68-0370244
(Commission File Number)   (I.R.S. Employer Identification No.)

 

400 S. Australian Avenue, Suite 800, West Palm Beach,
Florida
  33401
(Address of Principal Executive Offices)   (Zip Code)

 

(561) 855-1626
(Registrant’s Telephone Number, Including Area Code)

 

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered under Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on which registered
None   None   None

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 7.01. Regulation FD Disclosure

 

On June 16, 2022, Rennova Health, Inc. (the “Company”) issued a press release announcing that Seamus Lagan, our Chief Executive Officer, would be interviewed on Uptick Newswire’s “Stock Day” podcast with Sever Copley. A copy of the press release is attached hereto as Exhibit 99.1 and a transcript of the interview is attached hereto as Exhibit 99.2.

 

The information furnished pursuant to this Item 7.01, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01. Financial Statements and Exhibits

 

  (d) Exhibits

 

Exhibit No.   Exhibit Description
     
99.1   Press Release dated June 16, 2022
     
99.2   Transcript of Interview of Seamus Lagan
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

2
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: June 16, 2022 RENNOVA HEALTH, INC.
     
  By: /s/ Seamus Lagan
    Seamus Lagan
    Chief Executive Officer
    (principal executive officer)

 

3

EX-99.1 2 ex99-1.htm

 

Exhibit 99.1

 

 

RENNOVA HEALTH, INC. DISCUSSES PROGRESS AND PLANS FOR MENTAL AND BEHAVIORAL HEALTH DIVISION WITH THE STOCK DAY PODCAST

 

WEST PALM BEACH, Fla. (June 16, 2022) – Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan joined Stock Day host Sever Copley to discuss progress with the business and the Company’s plans to develop a mental and behavioral health division.

 

Copley started off by asking about the performance of the current hospital operations. Lagan stated his belief that the business was now stabilized, helped by the recently secured Critical Access Designation, and that he believed the operations would now be cash flow positive and generate a profit.

 

Copley went on to ask about the status of previously discussed plans to add mental and behavioral health to the business. Lagan confirmed that a new division, Myrtle Recovery Centers, Inc., had been created and that the Company was finalizing a plan to utilize available space at owned properties to provide these services. Lagan further explained that having space available reduced the capital needs to minor refurbishment and decorating costs and confirmed the intention to employ someone with specific knowledge of the industry to head up this new division.

 

Copley then asked what could be expected over a two or three year period from the Company. Lagan explained the continued need for rural healthcare and the Company’s plans to refine and prove a profitable model to create a foundation for further acquisitions in the future.

 

Copley finished by asking what message Lagan would like the Company’s shareholders to take away from the interview. Lagan responded by confirming his confidence that the Company can deliver an excellent service to its customers and make a profit for its shareholders

 

To hear Seamus Lagan’s entire interview, follow the link to the podcast here:

 

Stock Day Media / RENNOVA HEALTH, INC. DISCUSSES PROGRESS AND PLANS FOR MENTAL AND BEHAVIORAL HEALTH DIVISION WITH THE STOCK DAY PODCAST (audioboom.com)

 

Investors Hangout is a proud sponsor of “Stock Day,” and Stock Day Media encourages listeners to visit the company’s message board at https://investorshangout.com/

 

About Rennova Health, Inc.

 

Rennova Health, Inc. (“Rennova,” the “Company,” “we”, “us”, “its” or “our”) is a provider of health care services. The Company owns one operating hospital in Oneida, Tennessee known as Big South Fork Medical Center, a hospital located in Jamestown, Tennessee that it plans to reopen, a physician’s practice in Jamestown, Tennessee that it plans to reopen and a rural clinic in Kentucky. For more information, please visit www.rennovahealth.com

 

 
 

 

Forward-Looking Statements

 

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company’s most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

 

Contact:

 

Rennova Health

561-855-1626

info@rennovahealth.com

 

 

EX-99.2 3 ex99-2.htm

 

Exhibit 99.2

 

Rennova Health Interview

CEO Seamus Lagan on Uptick Newswire June 2022

 

Speakers: Sever Copley and Seamus Lagan

 

Copley: Welcome to the Stock Day Media Podcast. I am your host Sever Copley, filling in for Everett Jolly. On today’s show, I’m bringing back a returning guest. The last time they were on the show was at the end of April of this year. I’m talking about none other than Rennova Health, Inc. They trade on the OTC Pinks under the ticker symbol ‘RNVA’, and with us today is the CEO of the company, Mr. Seamus Lagan. He is going to bring us up-to-speed. Seamus, it is nice to meet you and welcome back to the show.

 

Lagan: It’s very nice to meet you, Sever. Hopefully, Everett will be back soon. In the meantime, I look forward to speaking to you.

 

Copley: Seamus, I wanted to check in and ask how the hospital business was performing. You have previously told us that you believe this business is now stabilized. I wanted to ask if that means you expect the business to be profitable? And can you tell us what you’re going to do to make it happen?

 

Lagan: We believe the recently secured critical access designation will enable a cash flow break even and hopefully a small profit. Monitoring and managing costs is an ongoing exercise in the facility and we have a lot of effort being applied to finding full-time employees right now to replace higher agency staffing costs. We believe more permanent and vested employees will facilitate increased patient flow and in turn, increase revenues. The combined result of these improvements will insure the long-term success of the facility, and we are glad that we see this facility stabilizing and turning a corner compared to where we were one or two years ago.

 

Copley: When you were last on the show, you spoke of preliminary plans to add behavioral and mental health services to your business, which I think is awesome by the way. Mental health is such an underserved need across the whole United States. What is the status of those plans and how do you see them developing in the coming months?

 

Lagan: We have now created Myrtle Recovery Centers, Inc. as a new wholly-owned division to develop these plans. It is early days, but we have already had a third-party specialist firm complete a short feasibility study for us and this appears to be a sector where the need for mental and behavioral health services is an expanding market in Tennessee. We have unused space in the properties that we own that can be converted with minimal capital expenditure and utilized to provide these services. We’re currently finalizing a plan and staffing requirements, and we intend to find someone with specific knowledge and a proven track record in the industry to head up this division. We will have to secure some additional capital to complete a launch, but already owning the assets to operate from, significantly reduces that need to minor refurbishment and decorating costs and some carry costs. This is a division, Sever, that we believe could significantly increase our current revenues and get us to overall profitability. So, we’re excited and hopeful that we can get this up and running sooner rather than later.

 

 
 

 

Copley: That sounds exciting. Now, through a number of very difficult years, you kept going and with a lot of hard work you have persevered. Where do you see this company going over the next two to three years, and what risks do you still have to overcome to get there?

 

Lagan: We continue to see an opportunity with rural hospitals. We have been building a management team that understands the sector very well, and we have refined a lot of our operations. There’s no question that there is a need for a certain level of care that can be conveniently accessed by rural communities. That need will continue to drive this opportunity, and if we can prove a model of combining mental and behavioral health side by side with hospital services, I believe we’ll be back on an acquisition and growth trajectory in the next year. As you said, it has been a difficult few years and we have a lot of employees who have weathered rough times with us. It would be really nice to get back to constructive growth as opposed to restructuring and firefighting.

 

Copley: What message would you like to give to your stockholders and our listeners today?

 

Lagan: Sever, I continue to be very confident that this company can deliver an excellent service to its customers, and a profit for our shareholders. We continue to say that we’ve had a difficult time, but we continue to work very hard to deliver that service and get to profitability and I do firmly believe that we are on track to change the history and have a much more positive future start to evolve here over the next one, two, three years and more.

 

Copley: Mr. Seamus Lagan, he is the CEO of Rennova Health, Inc. They trade on the OTC Pinks under the ticker symbol ‘RNVA’. Seamus, thank you so much for coming on the show. Hopefully, we will see you in another 45 to 55 days to give us an update.

 

Lagan: Thank you very much for your time and we look forward to it.

 

 

GRAPHIC 4 ex99-1_001.jpg begin 644 ex99-1_001.jpg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end EX-101.SCH 5 rnva-20220616.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 6 rnva-20220616_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 7 rnva-20220616_pre.xml XBRL PRESENTATION FILE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover
Jun. 16, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 16, 2022
Entity File Number 001-35141
Entity Registrant Name Rennova Health, Inc.
Entity Central Index Key 0000931059
Entity Tax Identification Number 68-0370244
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 400 S. Australian Avenue
Entity Address, Address Line Two Suite 800
Entity Address, City or Town West Palm Beach
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33401
City Area Code (561)
Local Phone Number 855-1626
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
XML 9 form8-k_htm.xml IDEA: XBRL DOCUMENT 0000931059 2022-06-16 2022-06-16 iso4217:USD shares iso4217:USD shares 0000931059 false 8-K 2022-06-16 Rennova Health, Inc. DE 001-35141 68-0370244 400 S. Australian Avenue Suite 800 West Palm Beach FL 33401 (561) 855-1626 false false false false false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 20 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://rennovahealth.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm ex99-1.htm ex99-2.htm rnva-20220616.xsd rnva-20220616_lab.xml rnva-20220616_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8-k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "form8-k.htm" ] }, "labelLink": { "local": [ "rnva-20220616_lab.xml" ] }, "presentationLink": { "local": [ "rnva-20220616_pre.xml" ] }, "schema": { "local": [ "rnva-20220616.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 20, "memberCustom": 0, "memberStandard": 0, "nsprefix": "RNVA", "nsuri": "http://rennovahealth.com/20220616", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2022-06-16to2022-06-16", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://rennovahealth.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2022-06-16to2022-06-16", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://rennovahealth.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 16 0001493152-22-016972-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-22-016972-xbrl.zip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end